Atlas Trials

Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer

Clinical trial NCT00086957 · COMPLETED

Trial details

NCT number
NCT00086957
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2004-01-01
Primary completion
2015-08-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.